Transcode Gross Profit from 2010 to 2025

RNAZ Stock

USD 3.35 0.16 5.02%

Transcode Therapeutics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Transcode Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-465.1 K

Current Value

-441.8 K

Quarterly Volatility

173.6 K

Credit Downgrade

Yuan Drop

Covid

Check Transcode Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Transcode Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 55.3 K, Tax Provision of 0.0 or Net Interest Income of 17.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 22.42. Transcode financial statements analysis is a perfect complement when working with Transcode Therapeutics Valuation or Volatility modules.

Check out the analysis of Transcode Therapeutics Correlation against competitors.

For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.

Latest Transcode Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Transcode Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Transcode Therapeutics minus its cost of goods sold. It is profit before Transcode Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Transcode Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Transcode Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Transcode Gross Profit Regression Statistics

	Arithmetic Mean	(126,993)
	Geometric Mean	70,357
	Coefficient Of Variation	(136.67)
	Mean Deviation	130,332
	Median	(42,470)
	Standard Deviation	173,562
	Sample Variance	30.1B
	Range	474.3K
	R-Value	(0.69)
	Mean Square Error	16.7B
	R-Squared	0.48
	Significance	0
	Slope	(25,303)
	Total Sum of Squares	451.9B

Transcode Gross Profit History

	2025	-441.8 K
	2024	-465.1 K
	2023	-516.7 K
	2022	-98.6 K

Other Fundumenentals of Transcode Therapeutics

Gross Profit Margin

Transcode Therapeutics Gross Profit component correlations

	Net Tangible Assets	Retained Earnings	Total Current Assets	Common Stock	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Investments	Deferred Long Term Liab	Current Deferred Revenue	Short Term Debt	Property Plant Equipment	Net Receivables
Net Tangible Assets		-0.34	0.98	0.29	0.97	0.99	-0.98	0.52	0.52	0.26	0.98	0.51	0.95	0.67	-0.16	-0.21	-0.22	-0.16	-0.16
Retained Earnings	-0.34		-0.39	0.55	-0.44	-0.25	0.26	-0.83	-0.78	-0.77	-0.18	0.27	-0.09	-0.89	0.63	0.92	0.97	0.63	0.63
Total Current Assets	0.98	-0.39		0.29	1.0	0.98	-0.99	0.61	0.63	0.41	0.97	0.56	0.95	0.72	-0.19	-0.27	-0.29	-0.19	-0.19
Common Stock	0.29	0.55	0.29		0.23	0.38	-0.4	-0.03	-0.24	-0.32	0.41	0.91	0.46	-0.2	0.6	0.59	0.48	0.6	0.6
Total Assets	0.97	-0.44	1.0	0.23		0.96	-0.97	0.64	0.66	0.45	0.95	0.51	0.93	0.75	-0.25	-0.33	-0.34	-0.25	-0.25
Total Stockholder Equity	0.99	-0.25	0.98	0.38	0.96		-1.0	0.48	0.48	0.22	1.0	0.59	0.98	0.61	-0.06	-0.12	-0.13	-0.06	-0.06
Net Debt	-0.98	0.26	-0.99	-0.4	-0.97	-1.0		-0.52	-0.53	-0.29	-0.99	-0.63	-0.98	-0.63	0.04	0.12	0.15	0.04	0.04
Accounts Payable	0.52	-0.83	0.61	-0.03	0.64	0.48	-0.52		0.83	0.81	0.43	0.3	0.36	0.93	-0.37	-0.73	-0.86	-0.37	-0.37
Long Term Debt	0.52	-0.78	0.63	-0.24	0.66	0.48	-0.53	0.83		0.94	0.46	0.13	0.43	0.87	-0.35	-0.63	-0.71	-0.35	-0.35
Total Liab	0.26	-0.77	0.41	-0.32	0.45	0.22	-0.29	0.81	0.94		0.2	0.04	0.18	0.75	-0.43	-0.7	-0.76	-0.43	-0.43
Net Invested Capital	0.98	-0.18	0.97	0.41	0.95	1.0	-0.99	0.43	0.46	0.2		0.62	0.99	0.56	-0.02	-0.05	-0.06	-0.02	-0.02
Capital Stock	0.51	0.27	0.56	0.91	0.51	0.59	-0.63	0.3	0.13	0.04	0.62		0.66	0.13	0.45	0.35	0.21	0.45	0.45
Net Working Capital	0.95	-0.09	0.95	0.46	0.93	0.98	-0.98	0.36	0.43	0.18	0.99	0.66		0.48	0.05	0.04	0.03	0.05	0.05
Short Term Investments	0.67	-0.89	0.72	-0.2	0.75	0.61	-0.63	0.93	0.87	0.75	0.56	0.13	0.48		-0.47	-0.77	-0.84	-0.47	-0.47
Deferred Long Term Liab	-0.16	0.63	-0.19	0.6	-0.25	-0.06	0.04	-0.37	-0.35	-0.43	-0.02	0.45	0.05	-0.47		0.86	0.63	1.0	1.0
Current Deferred Revenue	-0.21	0.92	-0.27	0.59	-0.33	-0.12	0.12	-0.73	-0.63	-0.7	-0.05	0.35	0.04	-0.77	0.86		0.94	0.86	0.86
Short Term Debt	-0.22	0.97	-0.29	0.48	-0.34	-0.13	0.15	-0.86	-0.71	-0.76	-0.06	0.21	0.03	-0.84	0.63	0.94		0.63	0.63
Property Plant Equipment	-0.16	0.63	-0.19	0.6	-0.25	-0.06	0.04	-0.37	-0.35	-0.43	-0.02	0.45	0.05	-0.47	1.0	0.86	0.63		1.0
Net Receivables	-0.16	0.63	-0.19	0.6	-0.25	-0.06	0.04	-0.37	-0.35	-0.43	-0.02	0.45	0.05	-0.47	1.0	0.86	0.63	1.0

Click cells to compare fundamentals

About Transcode Therapeutics Financial Statements

Transcode Therapeutics investors use historical fundamental indicators, such as Transcode Therapeutics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Transcode Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Gross Profit	-465.1 K	-441.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Transcode Stock Analysis

When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC